| Literature DB >> 24552128 |
Jonathan Erde1, Rachel R Ogorzalek Loo, Joseph A Loo.
Abstract
The integrity of quantitative proteomic experiments depends on the reliability and the robustness of the protein extraction, solubilization, and digestion methods utilized. Combinations of detergents, chaotropes, and mechanical disruption can yield successful protein preparations; however, the methods subsequently required to eliminate these added contaminants, in addition to the salts, nucleic acids, and lipids already in the sample, can result in significant sample losses and incomplete contaminant removal. A recently introduced method for proteomic sample preparation, filter-aided sample preparation (FASP), cleverly circumvents many of the challenges associated with traditional protein purification methods but is associated with significant sample loss. Presented here is an enhanced FASP (eFASP) approach that incorporates alternative reagents to those of traditional FASP, improving sensitivity, recovery, and proteomic coverage for processed samples. The substitution of 0.2% deoxycholic acid for urea during eFASP digestion increases tryptic digestion efficiency for both cytosolic and membrane proteins yet obviates needed cleanup steps associated with use of the deoxycholate sodium salt. For classic FASP, prepassivating Microcon filter surfaces with 5% TWEEN-20 reduces peptide loss by 300%. An express eFASP method uses tris(2-carboxyethyl)phosphine and 4-vinylpyridine to alkylate proteins prior to deposition on the Microcon filter, increasing alkylation specificity and speeding processing.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24552128 PMCID: PMC3993969 DOI: 10.1021/pr4010019
Source DB: PubMed Journal: J Proteome Res ISSN: 1535-3893 Impact factor: 4.466
Figure 1Enhancements to the FASP workflow. Samples are prepared in 4% SDS and diluted with 8 M urea to dissociate SDS from proteins. Microcon filter units and collection tubes are passivated by overnight incubation with 5% TWEEN-20, followed by thorough washing in MS-grade water. Diluted samples are then applied to passivated Microcon filters for buffer exchanges, eliminating SDS and contaminants. Proteins are alkylated with urea present, followed by successive buffer exchanges. Proteins are digested in the presence of surfactants, with the product peptides liberated by centrifugation. Extracting surfactant into an organic layer leaves behind pure peptides for fractionation or directly analysis by LC–MS.
(A) Compositions of E. coli Extraction Buffers, (B) Processing Conditions for the Eight 400 μg Aliquots of Standard Protein Mixture, (C) Filter-Aided Sample Preparation Buffer Components, and (D) E. coli Lysis Buffers Used to Evaluate eFASP with Surface Passivation
| (A) | ||
|---|---|---|
| extraction buffer | chaotrope | reductant/buffer |
| A | 12 mM DCA, 12 mM | 10 mM TCEP, 200 mM ABC, pH 8 |
| B | 12 mM DCA, 12 mM | 10 mM DTT, 200 mM ABC, pH 8 |
| C | 4% SDS | 10 mM DTT, 200 mM ABC, pH 8 |
ABC = 25 mM ABC. DCA = 0.1% DCA, 25 mM ABC.
DTT = 22 mM DTT. TCEP = 5.5 mM TCEP. DTT/TCEP = 11 mM DTT/2.8 mM TCEP.
IAN = 30 mM IAN. 4-VP = 25 mM 4-VP.
DTT = 22 mM DTT.
ABC = 25 mM ABC. DCA = 0.1% DCA, 25 mM ABC.
Analysis of an E. coli Lysate (163 μg) Processed and Digested by Traditional and Experimental Methodsa
| peptides | ||||||
|---|---|---|---|---|---|---|
| prep method | digest buffer | quantity (μg) | proteins | pass 1 | pass 2 | masses |
| 2DCleanupKit-0.1DCA | 0.1% DCA, ABC | 2 | 344 | 1965 | 4576 | 29 972 |
| FASP | ABC | 2 | 14 | 26 | 77 | 3736 |
| eFASP-0.1nOG | 0.1% nOG, ABC | 1 | 408 | 2141 | 5568 | 31 472 |
| eFASP-0.1DCA-0.1nOG | 0.1% DCA, ABC | 1 | 471 | 2678 | 6145 | 31 744 |
Lysate was either precipitated and digested in-solution in the presence of 0.1% DCA or cleaned in a Microcon filter unit and digested in the presence of ABC (FASP), 0.1% nOG (eFASP-0.1nOG), or 0.1% DCA (eFASP-0.1DCA). Each injection (1 or 2 μg, assuming complete recovery) was analyzed by LC–MSE and searched for (a) protein and peptide content and (b) predicted transmembrane helices (TMHs) in the identified protein sequences.
Figure 2Ion volumes for peptides quantified from the protocols (A) eFASP with 0.1% DCA versus eFASP with 0.1% nOG and (B) 2DCleanUpKit-0.1DCA versus eFASP with 0.1% nOG or 0.1% DCA and (C) eFASP with 0.1% nOG (blue) or 0.1% DCA (red) versus eFASP employing 0.1% of both nOG and DCA.
Analysis of an E. coli Lysate (50 μg) Processed by eFASP with Digestion Occurring in the Presence of 0.1% nOG, 0.1% DCA, 0.2% DCA, or the Combination of 0.1% nOG and 0.1% DCAa
| peptides | ||||
|---|---|---|---|---|
| prep method | digest buffer | proteins | pass 1 | pass 2 |
| eFASP-0.1nOG | 0.1% nOG, ABC | 202 | 989 | 3766 |
| eFASP-0.1DCA | 0.1% DCA, ABC | 253 | 1304 | 4947 |
| eFASP-0.2DCA | 0.2% DCA, ABC | 256 | 1392 | 4842 |
| eFASP-0.1DCA-0.1 nOG | 0.1% DCA, 0.1% nOG, ABC | 249 | 1394 | 4689 |
Each injection (400 ng, assuming complete recovery) was analyzed by LC–MSE and searched for (a) protein and peptide content and (b) predicted TMHs in the identified protein sequences.
Figure 3Protein identification overlap from eFASP processing of E. coli lysate with digestion buffers containing 0.1% nOG (green), 0.1% DCA (yellow), 0.2% DCA (red), and the combination of 0.1% DCA and 0.1% nOG (blue).
Figure 4GRAVY values for proteins identified in E. coli lysates processed by eFASP using different digestion buffers. GRAVY values were calculated for (A) all proteins identified in each digest or (B) proteins unique to one digest condition. (A) GRAVY values for all proteins are binned and plotted for eFASP-0.1DCA (light blue), eFASP-0.2DCA (dark blue), eFASP-0.1DCA-0.1nOG (magenta), and eFASP-0.1nOG (red). (B) GRAVY values are plotted for proteins unique to eFASP-0.1DCA (light blue), eFASP-0.2DCA (dark blue), eFASP-0.1DCA-nOG (magenta), and eFASP-0.1nOG (red).
Microcon Filter Units and Collection Tubes Were Incubated with Water or 5% T20 Overnighta
| peptides | |||||
|---|---|---|---|---|---|
| prep method | passivation | digest buffer | proteins | pass 1 | pass 2 |
| FASP | no | ABC | 21 | 85 | 229 |
| FASP-T20 | 5% T20 | ABC | 52 | 246 | 604 |
| eFASP-0.2DCA | no | 0.2% DCA, ABC | 252 | 1436 | 3645 |
| eFASP-0.2DCA-T20 | 5% T20 | 0.2% DCA, ABC | 284 | 1531 | 3671 |
Analysis of an E. coli lysate (50 μg) processed by eFASP with digestion occurring in the presence of ABC or 0.2% DCA. Each injection (100 ng, assuming complete recovery) was analyzed by LC–MSE and searched for (a) protein and peptide content and (b) predicted TMHs in the identified protein sequences.
Figure 5Sequence coverage for E. coli samples processed by eFASP with reduction and alkylation accomplished with either DTT/IAN (eFASP-0.2DCA-DTT/IAN, blue) or TCEP/4VP (eFASP-0.2DCA-TCEP/4VP, red).